Barclays raised the firm’s price target on Keurig Dr Pepper (KDP) to $39 from $37 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q2 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper: Strong Sales Growth and Attractive Valuation Drive Buy Rating
- Keurig Dr Pepper Reports Strong Q2 2025 Results
- Keurig Dr Pepper’s Earnings Call Highlights Growth Amid Challenges
- Morning Movers: Dow Inc. falls following Q2 report and dividend cut
- Keurig Dr Pepper reports Q2 adjusted EPS 49c, consensus 49c